Recorded device evidence

Enteral Feeding Sets (K240039): indications, design and recorded evidence

The acquired K240039 file contains product-specific indications and users, design and operating principle, recorded comparison and differences, non-clinical evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-07. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 31 selected decisions under primary code KNT. 31 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

Calendar elapsed days: lower quartile 55.0, median 110.0, upper quartile 175.0. These are recorded calendar differences, not active FDA review time.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K240039 ↗ · this pageEnteral Feeding Sets2024-01-05 → 2024-04-17103Traditional
K261890 ↗52Fr ViSiGi LUX™; 52Fr ViSiGi 3D®2026-06-05 → 2026-08-1470Special
K253514 ↗Minnesota Four-Lumen Esophagogastric Tamponade Tube - 18 French (0092220); Blakemore Esophageal-Nasogastric Tube - 20 French (0092100); Blakemore Esophageal-Nasogastric Tube - 16 French (0092300)2025-11-06 → 2026-07-10246Traditional
K250389 ↗XNY Disposable Gastric Calibration Tube2025-02-11 → 2025-04-1058Traditional
K243228 ↗Flexi-Seal AIR (with ENFit Connector)2024-10-08 → 2025-03-28171Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K240039 · PDF page 4 ↗ Source 2

Enteral Feeding Sets are intended to dispense liquid nutrition (feeding solutions) at a user controlled
   rate.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K240039 · PDF page 5 ↗ Source 3

The Enteral Feeding Sets have four models, Enteral Feeding Pump bag Set, Enteral Feeding Pump EnPlus
spike Set, Enteral Feeding Gravity bag Set, Enteral Feeding Gravity EnPlus spike Set.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Recorded comparison and differences

K240039 · PDF page 6 ↗ Source 4

➢      The subject device has the same intended use as the predicate device, dispense liquid nutrition (feeding

       solutions) at a user controlled rate.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

Non-clinical evidence actually described

K240039 · PDF page 10 ↗ Source 5

Read this statement in the original PDF; no complete statement fits the short excerpt.

Compare with your product: Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Historical references beside dated FDA recognition metadata

Read each mention in the linked original summary, including statements that testing was not performed. Recognition metadata does not determine your testing needs, chosen edition or transition eligibility.

Reference in this historical summaryDesignation in the acquired FDA exportRecognition / entry dateRecorded transition-expiration dateSources
ISO 80369-3:2016
Summary of Non-Clinical Testing
ISO 80369-3 First Edition 2016-07-01
Small-bore connectors for liquids and gases in healthcare applications - Part 3: Connectors for enteral applications [Including AMENDMENT 1 (2019)].
5-123 · Complete
07/15/2019
Not recorded in this export rowSummary [5] · Metadata [6]
Read scope and recognition limits ↗
ISO20695:2020
Summary of Non-Clinical Testing
ISO 20695 First edition 2020-03
Enteral feeding systems - Design and testing
9-138 · Complete
06/07/2021
Not recorded in this export rowSummary [5] · Metadata [7]
Read scope and recognition limits ↗
ISO18250-3:2018
Summary of Non-Clinical Testing
ISO 18250-3 First edition 2018-06
Medical devices - Connectors for reservoir delivery systems for healthcare applications - Part 3: Enteral application
5-139 · Complete
12/19/2022
Not recorded in this export rowSummary [5] · Metadata [8]
Read scope and recognition limits ↗
IEC62366-1:2020
Summary of Non-Clinical Testing
IEC 62366-1 Edition 1.1 2020-06 CONSOLIDATED VERSION
Medical devices - Part 1: Application of usability engineering to medical devices
5-129 · Complete
07/06/2020
Not recorded in this export rowSummary [5] · Metadata [9]
Read scope and recognition limits ↗
IEC62366-1:2020
Summary of Non-Clinical Testing
ANSI AAMI IEC 62366-1:2015+AMD1:2020 (Consolidated Text)
Medical devices Part 1: Application of usability engineering to medical devices including Amendment 1
5-129 · Complete
07/06/2020
Not recorded in this export rowSummary [5] · Metadata [10]
Read scope and recognition limits ↗

Prepare for your provider: the proposed protocol/report edition, its justification for your device and the complete current FDA recognition sheet. In particular, inspect exclusions for partial recognition. An edition difference does not automatically make the historical evidence unusable.

Identifier-matching method and selection limits

Match explicit ISO/IEC identifiers in selected preserved summary excerpts to the acquired, count-reconciled FDA metadata export. Preserve the historical edition mention, current snapshot designations, entry dates, recognition extent and any recorded transition-expiration date as separate facts. No title-similarity, edition-equivalence, test-mandate or transition-eligibility inference. At most twenty matched occurrences and thirty metadata rows per reference; wide matches are held for separate review.

4 of 4 matched reference occurrences shown.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK240039 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryEnteral Feeding Sets [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantHangzhou Primecare Medical Co., Ltd. [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeKNT [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2024-04-17 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2024-01-05 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Recorded comparison and differences — what differs in our product?

    The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

    Useful evidence: Feature-by-feature differences and the underlying cited documents; no automated predicate selection.

  4. Non-clinical evidence actually described — what differs in our product?

    Treat these as documented evidence themes in this case, including any limitations or negative statements. Ask which protocols, design inputs and acceptance rationale would be justified for your product; these excerpts are not a mandatory test panel.

    Useful evidence: Existing protocols/results and design-specific evidence gaps, with standard editions and scope reviewed separately.

  5. Which edition and recognition limits would our provider rely on?

    Compare each historical reference below with the dated FDA metadata. Ask the specialist to justify the applicable scope and selected edition, read the complete supplementary sheet for partial-recognition exclusions, and investigate any recorded transition conditions. A difference in editions does not automatically make the earlier study unusable.

    Useful evidence: Proposed protocol/report edition, dated FDA recognition sheet with scope/exclusions, and a documented edition/transition rationale for the actual device.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[12505] · record 3be18230eaac918e35680c97aacdcc1b6f2c18b690895d3f80ba8948407eafc0
  • [11] Complete results array / fda-decision-context:K240039 · record whole dataset partition

FDA 510(k) summary — K240039 ↗

Thu, 18 Apr 2024 13:33:32 GMT · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 8e8f1e02c33ddba8eaba56f77cd3cdef5b8a9e0a785e770c3dd904c276bc2b1b

  • [2] PDF page 4 · record 3bcf388e6b8f410ca0d25d504c83d3620e28e9e2340f38ebad5bcd545623d27d
  • [3] PDF page 5 · record 3398a79412728851527159d9a51a74e4b6132a782a1bb2d42347809ba239de4c
  • [4] PDF page 6 · record f674d2e69c193e20bf6e9b1afebb50e76b27c72f35e06cd5daf6548f05754399
  • [5] PDF page 10 · record 7872ee1319ee12a00fb36c2a4ea31de752cfe8217e6f90f64367d6994447b39d

FDA — recognition metadata exported through the official search form ↗

Version not stated by the source · retrieved 2026-10-07

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 94ccf56dc846c7f6d78d6ad77dc6e87d1803ac3612af01d6894949e34c4a78d8

  • [6] CSV row 1090 · record c19035286c97c432740e6994dce76be1a844df9b8e37f31d18cfd33c09f34131
  • [7] CSV row 820 · record b8108547f36a12d74089b5c6de5000b64de7c362eb1e5e14db7ce0adceeca7d0
  • [8] CSV row 602 · record 3011345afa03cdc231346827f3a0e5f01159f2048d828562d6e8952e14faaadd
  • [9] CSV row 947 · record 49b7be92881f78787d498dd3e1ce0c51091af1f6a0e0128d187ffbe6eb4056bd
  • [10] CSV row 948 · record ee03f33f8a3ca2e3f83cda53b0a08ecaec79fbe827e8d129b7edd4b1cbbac9ff

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services